Helen Stephens Group, LLC Novartis Ag Transaction History
Helen Stephens Group, LLC
- $337 Million
- Q4 2024
A detailed history of Helen Stephens Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Helen Stephens Group, LLC holds 4,222 shares of NVS stock, worth $460,409. This represents 0.12% of its overall portfolio holdings.
Number of Shares
4,222
Previous 4,222
-0.0%
Holding current value
$460,409
Previous $485,000
15.46%
% of portfolio
0.12%
Previous 0.15%
Shares
5 transactions
Others Institutions Holding NVS
# of Institutions
1,476Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.33 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.2 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$892 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$749 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$608 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $235B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...